| Jessica Teresia Greupner, MD | |
|
4300 Marketpointe Dr Ste 100, Bloomington, MN 55435-5435 | |
| (952) 835-9880 | |
| (952) 857-1554 |
| Full Name | Jessica Teresia Greupner |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 12 Years |
| Location | 4300 Marketpointe Dr Ste 100, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316387228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 60752 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Ulm Medical Center | New ulm, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
The COVID-19 pandemic is putting significant stress on college students, many of whom are worried about increasing financial pressures caused by the pandemic and the lack of easily accessible mental healthcare.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
› Verified 1 days ago
| Entity Name | Lakeview Memorial Hospital Association, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821114729 PECOS PAC ID: 1951210855 Enrollment ID: O20031104000543 |
News Archive
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
The COVID-19 pandemic is putting significant stress on college students, many of whom are worried about increasing financial pressures caused by the pandemic and the lack of easily accessible mental healthcare.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
› Verified 1 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
The COVID-19 pandemic is putting significant stress on college students, many of whom are worried about increasing financial pressures caused by the pandemic and the lack of easily accessible mental healthcare.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
› Verified 1 days ago
| Entity Name | Healthpartners Rc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649470782 PECOS PAC ID: 5890126726 Enrollment ID: O20200618000378 |
News Archive
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
The COVID-19 pandemic is putting significant stress on college students, many of whom are worried about increasing financial pressures caused by the pandemic and the lack of easily accessible mental healthcare.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Teresia Greupner, MD 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435-5435 Ph: (952) 835-9880 | Jessica Teresia Greupner, MD 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435-5435 Ph: (952) 835-9880 |
News Archive
New neuroscience research by life scientists from UCLA and Australia may potentially help people who have lost their ability to remember due to brain injury or disease.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
The COVID-19 pandemic is putting significant stress on college students, many of whom are worried about increasing financial pressures caused by the pandemic and the lack of easily accessible mental healthcare.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
› Verified 1 days ago
Rebecca Lynn Meyer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Dr. Holly Lynn Schrupp Berg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Andrew H Bauer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Laura Kuhlman, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 | |
Elisabeth Marycke Vreede Greenberg, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Leonardo A Saavedra, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 | |
Dr. Ferris Yeh, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4300 Marketpointe Dr Ste 100, Bloomington, MN 55435 Phone: 952-835-9880 Fax: 952-857-1554 |